Talk:Array BioPharma

Notability
PharmEditor (talk) 00:48, 4 January 2016 (UTC) This company is notable. It is in the NASDAQ biotechnology index. Please remove
 * Notability on Wikipedia is defined for companies at WP:CORP - and being listed a NASDAQ index is not in itself a means to demonstrate notability - although it would suggest adequate third-party sources may exist which would then establish notability.
 * Per WP:CORP: "A company, corporation, organization, school, team, religion, group, product, or service is notable if it has been the subject of significant coverage in secondary sources. Such sources must be reliable, and independent of the subject.  A single independent source is almost never sufficient for demonstrating the notability of an organization."
 * To establish notability, please demonstrate that multiple third-party source discuss the company (ie: not just listing them, nor simply mentioning them in passing, but provide depth of coverage). Note that press-releases reprinted by third-party sources are also not sufficient to demonstrate notability. --- Barek (talk • contribs) - 00:56, 4 January 2016 (UTC)

Needs independent sourcing
The following has almost no independent sourcing and was moved here per WP:PRESERVE. Per WP:BURDEN please do not restore without finding independent, reliable sources, checking the content against them, and citing them, and ensuring that this content has appropriate WP:WEIGHT in the article overall.

As of 2016, Array BioPharma has a number of compounds in clinical development.
 * Pipeline

-- Jytdog (talk) 19:49, 30 June 2017 (UTC)